Jeannine Kassis

6.4k citations

64 papers · 2.6k indexed · 1 hit paper · h-index 25

Internal Medicine top 0.2%
Surgery top 5%
Cardiology and Cardiovascular Medicine top 2%
Hematology top 1%
Emergency Medical Services top 0.5%

Co-authors: Susan Solymoss Susan R. Kahn Jeffrey S. Ginsberg André Roussin Sylvie Desmarais France Joyal Donna L. Lamping Mira Johri
Topics: Venous Thromboembolism Diagnosis and Management (21 papers)Acute Myeloid Leukemia Research (13 papers)Systemic Lupus Erythematosus Research (10 papers)
Cited by: Internal Medicine Hematology Emergency Medical Services
Journals: New England Journal of Medicine Journal of Clinical Oncology Blood
Partner nations: Canada United States United Kingdom

In The Last Decade

Jeannine Kassis

64 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

2003 544 citations Clive Kearon, Jeffrey S. Ginsberg et al. profile →

Peers

Countries citing papers authored by Jeannine Kassis

Since Specialization

Citations

This map shows the geographic impact of Jeannine Kassis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeannine Kassis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeannine Kassis more than expected).

Fields of papers citing papers by Jeannine Kassis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeannine Kassis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeannine Kassis. The network helps show where Jeannine Kassis may publish in the future.

Co-authorship network of co-authors of Jeannine Kassis

This figure shows the co-authorship network connecting the top 25 collaborators of Jeannine Kassis. A scholar is included among the top collaborators of Jeannine Kassis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeannine Kassis. Jeannine Kassis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia 2021 ·Blood Advances ·Manraj Kaur,Donald M. Arnold,Nancy M. Heddle,Richard J. Cook,Cyrus C. Hsia,Mark Blostein,Erin Jamula,Michelle Sholzberg,Yulia Lin,Jeannine Kassis,Loree Larratt,Alan Tinmouth,Julie Carruthers,Na Li,Yang Liu,Feng Xie	9
2	Long‐term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS‐PTS study 2020 ·Journal of Thrombosis and Haemostasis ·J.‐P. Galanaud,Marc Righini,(unknown),Aymeric Douillard,Helia Robert‐Ebadi,Daniel Pontal,David Morrison,M.‐T. Barrellier,A. Diard,(unknown),D. Brisot,(unknown),Sandrine Accassat,(unknown),Aurélien Delluc,Susan Solymoss,Jeannine Kassis,Marc Carrier,I. Quéré,Susan R. Kahn	22
3	Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline 2018 ·Blood Coagulation & Fibrinolysis ·Carlos Aguilar,Michelangelo Sartori,Armando D’Angelo,Christopher Kabrhel,J. B. Groce,Emmanuel de Maistre,Suman Wasan,Jeannine Kassis,John Lazarchick,(unknown),Pascual Marco,Jeffrey A. Kline,D. Mark Courtney,Andrew Rubin,Mel J. Sharafuddin,Gilles Pernod	5
4	Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial 2017 ·The Lancet Haematology ·Asher Chanan‐Khan,Andrey Zaritskey,Miklós Egyed,Samuel Vokurka,С. В. Семочкин,Anna Schuh,Jeannine Kassis,David Simpson,Jennie Zhang,(unknown),Robin Foà	29
5	Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study 2016 ·Blood Coagulation & Fibrinolysis ·Gilles Pernod,Haifeng Wu,Emmanuel de Maistre,John Lazarchick,Jeannine Kassis,Carlos Aguilar,Pascual Marco,Gualtiero Palareti,Armando D’Angelo	14
6	Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment 2015 ·Current Oncology ·Jacob C. Easaw,Melissa Shea‐Budgell,Chengliang Wu,Piotr Czaykowski,Jeannine Kassis,(unknown),(unknown),Mary MacNeil,(unknown),(unknown),(unknown),Otto Moodley,Sudeep Shivakumar,Vicky Tagalakis,S. Welch,Petr Kavan	38
7	Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis 2015 ·Current Oncology ·Jacob C. Easaw,Melissa Shea‐Budgell,Chengliang Wu,Piotr Czaykowski,Jeannine Kassis,(unknown),Howard J. Lim,Mary MacNeil,(unknown),Phil McFarlane,(unknown),Otto Moodley,Sudeep Shivakumar,Vicky Tagalakis,S. Welch,Petr Kavan	55
8	An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes 2014 ·Leukemia Research Reports ·Stuart L. Goldberg,Pierre Fenaux,Michael Craig,Emmanuel Gyan,John Lister,Jeannine Kassis,Arnaud Pigneux,Gary J. Schiller,JungAh Jung,E. Jane Leonard,Howard Fingert,Peter Westervelt	66
9	Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus. 2013 ·PubMed ·Joseph Brandwein,Michelle Geddes,Jeannine Kassis,Andrea Kew,Brian Leber,Thomas J. Nevill,Mitchell Sabloff,Irwindeep Sandhu,Andre C. Schuh,John M. Storring,John Ashkenas	12
10	Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada 2012 ·Journal of Medical Economics ·(unknown),(unknown),Robert Deuson,Jeannine Kassis,Vinçent Laroche	10
11	Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation 2011 ·Journal of Thrombosis and Haemostasis ·(unknown),Thiérry Ducruet,Mira Johri,M.‐J. Miron,André Roussin,Sylvie Desmarais,France Joyal,Jeannine Kassis,Susan Solymoss,Jeffrey S. Ginsberg,Donna L. Lamping,Ian Shrier,Susan R. Kahn	118
12	Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study 2011 ·Clinical Lymphoma Myeloma & Leukemia ·Aaron D. Schimmer,Wolfgang Herr,Mathias Hänel,G. Borthakur,Arthur E. Frankel,(unknown),Sonja Martin,Jeannine Kassis,P. Desjardins,Karen Seiter,Walter Fiedler,Richard Noppeney,Aristoteles Giagounidis,Christine Jacob,Jacques Jolivet,Martin S. Tallman,Steffen Koschmieder	41
13	A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial 2008 ·BMC Cancer ·Jorge Sierra,Jeff Szer,Jeannine Kassis,Richard Herrmann,Mario Lazzarino,Xavier Thomas,Stephen J. Noga,Nigel Baker,Roger Dansey,Alberto Bosi	40
14	Determinants of health‐related quality of life during the 2 years following deep vein thrombosis 2008 ·Journal of Thrombosis and Haemostasis ·Susan R. Kahn,Hadia Shbaklo,Donna L. Lamping,Christina Holcroft,Ian Shrier,M.‐J. Miron,André Roussin,Sylvie Desmarais,France Joyal,Jeannine Kassis,Susan Solymoss,Louis Desjardins,Mira Johri,Jeffrey S. Ginsberg	370
15	Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial 2008 ·Blood ·Clive Kearon,Jim A. Julian,Michael J. Kovacs,David R. Anderson,Philip Wells,Betsy MacKinnon,Jeffrey I. Weitz,Mark Crowther,Sean Dolan,Alexander G.G. Turpie,William Geerts,Susan Solymoss,Paul Nguyen,Christine Demers,Susan R. Kahn,Jeannine Kassis,Marc Rodger,Julie Hambleton,Michael Gent,Jeffrey S. Ginsberg	81
16	Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis 2005 ·Journal of Thrombosis and Haemostasis ·Susan R. Kahn,Clive Kearon,J.A. Julian,Betsy MacKinnon,M.J. Kovacs,Philip Wells,Mark Crowther,David R. Anderson,(unknown),C. Demers,Susan Solymoss,Jeannine Kassis,William Geerts,Marc Rodger,J. Hambleton,Jeffrey S. Ginsberg	147
17	Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis 2004 ·Thrombosis and Haemostasis ·Jeannine Kassis,Carolyn Neville,Joyce Rauch,Lambert Busque,Erika Chang,Lawrence Joseph,(unknown),Rebecca Subang,Paul R. Fortin	16
18	Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease 2002 ·Scandinavian Journal of Rheumatology ·Sophie Ligier,(unknown),Andrew Watters,Jeannine Kassis,Paul R. Fortin	9
19	Prevention of Venous Thromboembolism after Knee Arthroplasty 1996 ·Annals of Internal Medicine ·Jacques R. Leclerc,William Geerts,Louis Desjardins,(unknown),(unknown),Christine Demers,Jeannine Kassis,Moira Cruickshank,(unknown),F. Delorme	25
20	Allogeneic bone marrow transplantation following busulfan‐cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukaemia 1993 ·British Journal of Haematology ·(unknown),Robert Bélanger,Claude Perreault,Y Bonny,Denis‐Claude Roy,(unknown),Jeannine Kassis,(unknown),Michel Lacombe,M Gyger	12

About Jeannine Kassis

Jeannine Kassis is a scholar working on Internal Medicine, Hematology and Family Practice, having authored 64 papers that have together received 2.6k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (21 papers), Acute Myeloid Leukemia Research (13 papers) and Systemic Lupus Erythematosus Research (10 papers). The work is most often cited by research in Internal Medicine (1.5k citations), Hematology (756 citations) and Emergency Medical Services (398 citations). Jeannine Kassis has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Susan Solymoss, Susan R. Kahn, Jeffrey S. Ginsberg, André Roussin, Sylvie Desmarais, France Joyal, Donna L. Lamping, Mira Johri, Ian Shrier and Louis Desjardins. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact